Location History:
- Akersberga, SE (1998)
- .ANG.kersberga, SE (1999)
Company Filing History:
Years Active: 1998-1999
Title: The Innovative Contributions of Erik Walum
Introduction
Erik Walum is a notable inventor based in Akersberga, Sweden. He has made significant contributions to the fields of obesity treatment and protein production, holding a total of 2 patents. His work focuses on developing methods that can potentially revolutionize the treatment of metabolic disorders.
Latest Patents
One of Erik Walum's latest patents is titled "Methods of screening for modulators of uncoupling protein-2 (UCP-2)." This invention relates to a method for treating obesity, metabolic syndrome, and non-insulin dependent diabetes mellitus. It involves administering a drug that modulates the regulation of UCP-2. The patent also covers the use of such a drug for producing medications aimed at these conditions, along with pharmaceutical compositions containing effective amounts of the drug. Additionally, the invention includes methods for screening potential drugs against these metabolic disorders using cDNA probes to determine the upregulation of UCP-2.
Another significant patent by Walum is a "Process for producing a protein." This process aims to reduce the negative impact of certain proteases on the production of recombinant human proteins and polypeptides in cell cultures. It involves adding inhibitors of metal-dependent proteases or chymotrypsins to the culture medium. The resulting recombinant factor VIII produced through this method is beneficial for treating hemophilia A by providing a therapeutically effective amount of the protein to patients.
Career Highlights
Erik Walum is currently associated with Pharmacia & Upjohn AB, where he continues to innovate in the pharmaceutical field. His work has the potential to address significant health challenges related to obesity and metabolic disorders.
Collaborations
Throughout his career, Erik has collaborated with notable colleagues, including Lars Adamson and Johan Dixelius. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Erik Walum's innovative work in the pharmaceutical industry showcases his commitment to addressing critical health issues through scientific research and development. His patents reflect a deep understanding of metabolic disorders and protein production, positioning him as a valuable contributor to modern medicine.